factor

(redirected from hematopoietic growth factor)
Also found in: Dictionary, Thesaurus, Medical, Legal, Encyclopedia.

Factor

A financial institution that buys a firm's accounts receivable and collects the accounts.

Factor

A third party that buys a firm's accounts receivable. If a firm is not confident in its ability to collect on its credit sales, it may sell the right to receive payment to the factor at a discount. The factor then assumes the credit risk associated with the accounts receivable. This provides the firm immediate access to working capital, which is important, especially if the firm has a cash flow problem. The price of factoring is determined by the creditworthiness of the firm's customer, not of the firm itself. It is also known as accounts receivable financing.

factor

A firm that purchases accounts receivable from another firm at a discount. The purchasing firm then attempts to collect the receivables.

factor

To sell accounts receivable to another party at a discount from face value. Thus, a firm in need of cash to pay down short-term debt may decide to factor its accounts receivable to another firm.

factor

  1. a firm that purchases TRADE DEBTS from client firms. See FACTORING.
  2. a firm that buys in bulk and performs a WHOLESALING function.
  3. an input (for example raw material, labour, capital) which is used to produce a good or provide a service.

factor

  1. 1a FACTOR INPUT that is used in production (see NATURAL RESOURCES, LABOUR, CAPITAL).
  2. a business that buys in bulk and performs a WHOLESALING function.
  3. a business that buys trade debts from client firms (at some agreed price below the nominal value of the debts) and then arranges to recover them for itself. See FACTOR MARKET, FACTORING.
References in periodicals archive ?
Ferro and his associates noted that "the role of supportive agents such as hematopoietic growth factors cannot be considered simple additive costs.
Contract notice: provision of antineoplastic and immunomodulatory drugs, hematopoietic growth factors - intermediate procedure
This dialogue within BM cell populations takes place through numerous extracellular and intracellular factors including hematopoietic growth factors and their receptors, signaling pathways, and cell cycle signaling [2].
The book covers indications for transfusions of several specialized products, such as red cells, platelets, granulocytes, hemostatic agents, mononuclear cells, immune globulin, and hematopoietic growth factors, as well as others.
Recent evidences support the notion that patients with myeloid malignancies may present bone marrow microenvironment alterations in terms of abnormal hematopoietic-to-stromal cell interactions, relative deficiency of hematopoietic growth factors, and aberrant release of inhibitors [1].

Full browser ?